Kumar A, Singh V, Tiwari R, Madhukar P, Rajneesh , Kumar S
Front Immunol. 2023; 14:1236952.
PMID: 37638047
PMC: 10451093.
DOI: 10.3389/fimmu.2023.1236952.
Goyal V, Rabi Das V, Singh S, Singh R, Pandey K, Verma N
PLoS Negl Trop Dis. 2020; 14(7):e0008429.
PMID: 32687498
PMC: 7392342.
DOI: 10.1371/journal.pntd.0008429.
Gedda M, Singh B, Kumar D, Singh A, Madhukar P, Upadhyay S
PLoS Negl Trop Dis. 2020; 14(7):e0008221.
PMID: 32614818
PMC: 7332242.
DOI: 10.1371/journal.pntd.0008221.
Sengupta R, Chaudhuri S, Moulik S, Ghosh M, Saha B, Das N
PLoS Negl Trop Dis. 2019; 13(3):e0007249.
PMID: 30856178
PMC: 6428339.
DOI: 10.1371/journal.pntd.0007249.
Zijlstra E, Alves F, Rijal S, Arana B, Alvar J
PLoS Negl Trop Dis. 2017; 11(11):e0005877.
PMID: 29145397
PMC: 5689828.
DOI: 10.1371/journal.pntd.0005877.
Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
Ramesh V, Kaushal H, Mishra A, Singh R, Salotra P
BMC Public Health. 2015; 15:1092.
PMID: 26503551
PMC: 4621871.
DOI: 10.1186/s12889-015-2424-8.
PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
Ganguly S, Saha P, Chatterjee M, Roy S, Ghosh T, Guha S
PLoS Negl Trop Dis. 2015; 9(10):e0004138.
PMID: 26485704
PMC: 4613818.
DOI: 10.1371/journal.pntd.0004138.
The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.
Hartley M, Drexler S, Ronet C, Beverley S, Fasel N
Trends Parasitol. 2014; 30(8):412-22.
PMID: 24954794
PMC: 4287268.
DOI: 10.1016/j.pt.2014.05.006.
Post kala-azar dermal leishmaniasis: an unresolved mystery.
Mukhopadhyay D, Dalton J, Kaye P, Chatterjee M
Trends Parasitol. 2014; 30(2):65-74.
PMID: 24388776
PMC: 3919212.
DOI: 10.1016/j.pt.2013.12.004.
Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.
Islam S, Kenah E, Bhuiyan M, Rahman K, Goodhew B, Ghalib C
Am J Trop Med Hyg. 2013; 89(2):345-53.
PMID: 23817330
PMC: 3741258.
DOI: 10.4269/ajtmh.12-0711.
Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis.
Koley S, Mandal R, Choudhary S, Bandyopadhyay A
Indian J Dermatol. 2013; 58(3):241.
PMID: 23723490
PMC: 3667302.
DOI: 10.4103/0019-5154.110848.
Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
Katara G, Ansari N, Singh A, Ramesh V, Salotra P
PLoS Negl Trop Dis. 2012; 6(6):e1703.
PMID: 22724038
PMC: 3378621.
DOI: 10.1371/journal.pntd.0001703.
